康复新液及重组牛碱性成纤维细胞生长因子治疗放射性皮炎的临床应用研究进展  

Advance in research of Kangfuxin solution and recombinant bovine basic fibroblast growth factor in the treatment of radiodermatitis

作　　者：余艳梅[1] 韦妹爱[1] 刘丽琼 蒙以良[1] 李月明 YU Yanmei;WEI Meiai;LIU Liqiong;MENG Yiliang;LI Yueming(Department of Cancer Radiotherapy,Peopled Hospital of Baise,Baise,Guangxi,533000)

机构地区：[1]广西壮族自治区百色市人民医院肿瘤放疗科

出　　处：《中西医结合护理（中英文）》2019年第12期145-148,共4页Journal of Clinical Nursing in Practice

基　　金：广西百色市科学研究与技术开发计划项目(20192516)

摘　　要：本文探讨了康复新液及重组牛碱性成纤维细胞生长因子(rb-bFGF)治疗放射性皮炎的临床应用,对放射性皮炎的发病机制、康复新液和rb-bFGF的药理作用及临床应用进行了阐述。This paper reviewed the clinical researches of Kangfuxin solution and recombinant bovine basic fibroblast growth factor(rb-bFGF) in the treatment of radiodermatitis, and briefly discussed the pathogenesis of radiodermatitis, pharmacological action of Kangfuxin solution and rb-bFGF, and clinical application.

关 键 词：康复新液 重组牛碱性成纤维细胞生长因子 放射性皮炎 放射治疗 

分 类 号：R473.73[医药卫生—护理学]